Editorial : Opioids in the time of the COVID-19 pandemic : from cellular mechanisms to public health policy

dc.contributor.authorJohn, Scott
dc.contributor.authorWalwyn, David Richard
dc.contributor.authorDeFea, Kathryn
dc.contributor.authorHales, Tim G.
dc.contributor.authorWalwyn, Wendy
dc.date.accessioned2024-06-21T09:28:24Z
dc.date.available2024-06-21T09:28:24Z
dc.date.issued2023-07-14
dc.description.abstractNo abstract available.en_US
dc.description.departmentGraduate School of Technology Management (GSTM)en_US
dc.description.librarianam2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.urihttp://www.frontiersin.org/Pharmacologyen_US
dc.identifier.citationJohn, S., Walwyn, D.R., DeFea, K., Hales, T.G. & Walwyn, W. (2023), Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy. Frontiers in Pharmacology 14:1251958. DOI: 10.3389/fphar.2023.1251958.en_US
dc.identifier.issn1663-9812 (online)
dc.identifier.other10.3389/fphar.2023.1251958
dc.identifier.urihttp://hdl.handle.net/2263/96591
dc.language.isoenen_US
dc.publisherFrontiers Mediaen_US
dc.rights© 2023 John, Walwyn, DeFea, Hales and Walwyn. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).en_US
dc.subjectOpioid use disorderen_US
dc.subjectSubstance use disorderen_US
dc.subjectOpioid use disorder treatmenten_US
dc.subjectSubstance use disorder treatmenten_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectCoronavirus disease 2019 (COVID-19)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.subjectEditorialen_US
dc.titleEditorial : Opioids in the time of the COVID-19 pandemic : from cellular mechanisms to public health policyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
John_Editorial_2023.pdf
Size:
529.54 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: